Jarvis
  • CATEGORIES
    • Equity Markets
    • Investing Basics
    • AI for investing
    • Trending Stock Market News: Quick Reads
    • Portfolio Management
    • Stock Market News Updates
    • Global Stock Market
    • Stock Advisory
  • I AM A
    • Beginner
    • Intermediate
  • Home
  • Products
    • Jarvis Portfolio
    • Jarvis Protect
    • Jarvis OneStock
    • Jarvis Prime – For HNIs & UHNIs
    • Jarvis Sentiment Tracker – AI Tool for F&O
    • Jarvis US Multi-Asset Portfolio
    • Jarvis Atlas
  • FAQs
  • About Us
  • Contact Us
  • Become a Partner
No Result
View All Result
Jarvis
  • CATEGORIES
    • Equity Markets
    • Investing Basics
    • AI for investing
    • Trending Stock Market News: Quick Reads
    • Portfolio Management
    • Stock Market News Updates
    • Global Stock Market
    • Stock Advisory
  • I AM A
    • Beginner
    • Intermediate
  • Home
  • Products
    • Jarvis Portfolio
    • Jarvis Protect
    • Jarvis OneStock
    • Jarvis Prime – For HNIs & UHNIs
    • Jarvis Sentiment Tracker – AI Tool for F&O
    • Jarvis US Multi-Asset Portfolio
    • Jarvis Atlas
  • FAQs
  • About Us
  • Contact Us
  • Become a Partner
No Result
View All Result
Jarvis
No Result
View All Result
Home Stock Market News Updates

Wednesday, 22nd December 2021

by Sumit Chanda
December 22, 2021
in Stock Market News Updates
Reading Time: 4 mins read
A A
0
Share on FacebookShare on Twitter

SBI acquired a minority stake in JSW Cement with an investment of Rs.100 crore via CCPS. The conversion of CCPS into equity will be linked to the company’s future business performance. The capital infusion by SBI will help JSW Cement expand its cement capacity from 14 MTPA to 25 MTPA. Recently, Apollo Global and Synergy Metals had also picked up a stake in JSW Cement. The JSW statement was quite clear that they looked to leverage the experience and expertise of SBI, ahead of their proposed IPO in next one year. 

Shares of Piramal Enterprises surged 4% after its Piramal Pharma unit announced it had acquired 27.78% stake in Yapan Bio. Now Yapan Bio is a CDMO company focusing on contract process development and manufacturing. It is located at the Genome valley in Hyderabad. The total stake buy is worth Rs.102 crore. It adds to Piramal Pharma’s existing capabilities in development and manufacturing of large molecules for human clinical trials. Within the CDMO segment, Biologics remains the fastest growing segment in CDMO.

The Shareholders of MOIL approved the buy back over 3.38 crore shares of MOIL with record date on 31-December. In all, MOIL will buy back 3,38,42,668 equity share at Rs.205 per share for cash having an overall value of Rs.693.77 crore. This buyback represents nearly 14.26% of the total number of shares in the paid-up share capital of MOIL. The PSU company, MOIL, comes under the purview of Ministry of Steel. MOIL is India’s largest manganese ore mining company and contributes 40% of the total mining revenues.

Adani Enterprises was up 2% after it announced it had secured the contract to implement the 3 key stretches of the greenfield Ganga Expressway. The Ganga Expressway will entail a total investment outlay of Rs.17,085 crore and will be the longest expressway under the PPP route. The project will have a construction period of 3 years and concession shall be 30 years. Adani now has 13 projects in its roads portfolio covering 5,000 KM and asset value in excess of Rs.35,000 crore as part of Bharat Mala project.

Snapdeal, which is backed by Softbank of Japan, filed its DRHP to raise Rs.1,250 crore via fresh issue and offer 30,769,600 equity shares. However, the two founding promoters viz. Kunal Bahl and Rohit Bansal will not be selling any of their stock in the IPO. Selling shareholders in the IPO will include SoftBank, Foxconn, Myriad Opportunities, Madison India, Sequoia Capital and Ontario Teacher’s Pension Fund. Snapdeal will utilize the proceeds of the fresh issue to fund growth and expand logistics capabilities. 

The Indian rupee has been among Asia’s worst-performing currencies recently, with foreign funds selling heavily in Indian stocks. The $4 billion outflow by FPIs has resulted in the INR weakening by 2.2%. A slew of global brokers like Nomura, Morgan Stanley and Goldman Sachs lower their outlook for Indian equities citing lofty valuations. The recent hawkishness by the Fed and the spreading Omicron variant has also put pressure on the rupee. Ironically, other Asian EMs have been getting consistent FPI flows in this month.

Axis Bank has reportedly emerged as the top bidder to buy Citi’s consumer banking business. It may be recollected that in Apr-21, Citibank had announced plans to exit consumer banking business in India as part of its global strategy. In the case of Citi, the consumer banking business encompasses credit cards, retail banking, home loans and wealth management. The valuation for the business may be in the vicinity of $2 billion. Citi is one of the oldest banks in India, since 1902, and had started consumer banking in 1985.

Shree Cement will set up a Rs.1,500 crore cement plant in the Guntur district of Andhra Pradesh It will be a Greenfield Cement plant in Guntur. Shree Cements is the second largest cement manufacturer in India in terms of cement manufacturing capacity after Ultratech. This will be their first plant in the state of AP and the project will be completed in 24 months. Shree reported Rs.578 crore profit in the Sep-21 quarter while revenues in the quarter stood at Rs.3,206 crore. This will be the tenth state for cement presence.

Sumit Chanda

Sumit Chanda

Sumit has 18 years of experience in BFSI industry, into devising strategy for various functions, Investments and Managing Asset Portfolios. Specializes in Strategy & implementation in sales & operations, Team management, IT implementation, Affiliations.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Jarvis Invest

India's AI-powered, SEBI-registered investment advisory — research, portfolios and global market intelligence for every investor.

Company

  • About Us
  • FAQs
  • Contact Us
  • Become a Partner

Products

  • Jarvis Portfolio
  • Jarvis Protect
  • Jarvis OneStock
  • Jarvis Prime
  • Sentiment Tracker (F&O)
  • US Multi-Asset Portfolio

Explore Topics

  • Equity Markets
  • Investing Basics
  • AI for investing
  • Trending Stock Market News: Quick Reads
  • Financial Planning
  • Portfolio Management
  • Stock Market News Updates
  • Global Stock Market

Get in touch

Customer support customersupport@jarvisinvest.com

Jarvis Invest — SEBI Registered Investment Adviser (Reg. No. INA000013235) & SEBI Registered Research Analyst (Reg. No. INH000018762). Investments in the securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

© 2026 Jarvis Invest. All rights reserved.

  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
Categories
Equity MarketsGet latest insights on the Indian equity market including stock trends, market analysis, sector…Investing BasicsLearn stock market basics including investing fundamentals, equity concepts, and beginner-friendly guides to start…AI for investingStay ahead with AI-powered stock insights, trend analysis, and intelligent investing strategies for ai…Trending Stock Market News: Quick ReadsDiscover the latest trends in the stock market with insightful blogs from Jarvis Invest…Portfolio ManagementExpert insights on portfolio management, asset allocation, risk management, and strategies to optimise best…Stock Market News UpdatesGet daily stock market news updates, key market movements, and insights that matter to…Global Stock MarketGet latest global stock market news, trends, and AI-driven stock insights on US, Europe…Stock AdvisoryLearn how AI-powered stock advisory and expert market research can help you build wealth.
I Am A
BeginnerBeginner-friendly stock market guides covering investing basics, common mistakes, and simple strategies to build…IntermediateIntermediate-level stock market insights covering investment strategies, portfolio analysis, and market concepts for informed…
Products
Jarvis PortfolioModel portfolio matched to your risk profile for long-term wealth creation.Jarvis ProtectContinuous portfolio monitoring for your existing portfolio with timely sell alerts to help manage downside risk.Jarvis OneStockHigh-conviction stock recommendations designed for short-term investing.Jarvis Prime - For HNIs & UHNIsPremium portfolio management services for investors with ₹25 lakh+ investment corpus.Jarvis Sentiment Tracker - AI Tool for F&OReal-time market sentiment analysis and trading signals for options traders.Jarvis US Multi-Asset PortfolioDiversified US portfolio investing across stocks and ETFs with automated portfolio management.Jarvis AtlasInvestment opportunities across Indian equities, global markets, and commodities in 10+ global markets.
No Result
View All Result
  • CATEGORIES
    • Equity Markets
    • Investing Basics
    • AI for investing
    • Trending Stock Market News: Quick Reads
    • Portfolio Management
    • Stock Market News Updates
    • Global Stock Market
    • Stock Advisory
  • I AM A
    • Beginner
    • Intermediate
  • Home
  • Products
    • Jarvis Portfolio
    • Jarvis Protect
    • Jarvis OneStock
    • Jarvis Prime – For HNIs & UHNIs
    • Jarvis Sentiment Tracker – AI Tool for F&O
    • Jarvis US Multi-Asset Portfolio
    • Jarvis Atlas
  • FAQs
  • About Us
  • Contact Us
  • Become a Partner

© 2023 Jarvis Invest

Go to mobile version